Bax is a proapoptotic protein implicated in cell death involved in several neurodegenerative diseases. Intracellularly expressed antibody (Ab) fragments (intrabodies) inhibiting Bax function would have potential for developing therapeutics for the aforementioned diseases and can serve as research tools. We report identification, cloning, and functional characterization of several Bax-specific single-domain antibodies (sdAbs). These minimal size Ab fragments, which were isolated from a llama V H H phage display library by panning, inhibited Bax function in in vitro assays. Importantly, as intrabodies, these sdAbs, which were stably expressed in mammalian cells, were nontoxic to their host cells and rendered them highly resistant to oxidative-stress-induced apoptosis. The intrabodies prevented mitochondrial membrane potential collapse and apoptosis after oxidative stress in the host cells. These anti-Bax V H Hs could be used as tools for studying the role of Bax in oxidative-stress-induced apoptosis and for developing novel therapeutics for the degenerative diseases involving oxidative stress. 
Programmed cell death or apoptosis is a physiological process essential for normal development and tissue homeostasis. Although the existence of cell death mechanisms is a protective measure for organisms that ensures the removal of unnecessary, damaged, or potentially dangerous cells, any deregulation or inappropriate induction of this process leads to the loss of healthy cells causing diseases. In particular, cell death in postmitotic tissues like brain and heart in adult organisms results in functional compromise, as is the case in Alzheimer's disease, Parkinson's disease (PD), and stroke. Cell death induced by oxidative stress has been shown to be involved in the development of these pathologies (1) . Although the exact mechanism of cell death induced by oxidative stress is still unknown, mitochondria have been shown to play a central role in this process. Mitochondrial events such as opening of the permeability transition pores, mitochondrial membrane potential collapse, and release of proapoptotic factors such as cytochrome c and/or apoptosis inducing factors trigger the cascade of events leading to execution of apoptosis.
Bax is a 24 kDa protein of the Bcl-2 family with proapoptotic function. It normally resides in cytosol and translocates to mitochondria on induction of apoptosis, and it plays a key role in destabilizing mitochondria. Translocation of Bax to mitochondria followed by a conformational change in association with Bid leads to the release of cytochrome c, apoptosis-inducing factor, and caspase-9, which start the execution phase of apoptosis (2, 3) . Bax has been implicated in neuronal cell death during embryonic development and ischemia (4, 5) . Since Bax is involved in the early phase of apoptosis, developing specific blockers of Bax could protect neurons from oxidative-stress-induced apoptosis that is implicated in a number of neurodegenerative diseases.
Intrabodies to Bax with inhibitory action would have potential for the therapy of neurodegenerative disorders (6) , in addition to being valuable tools for studying apoptosis. The efficacy of intrabodies critically depends on their stability (7) (8) (9) (10) . Since in the reducing environment of the cytoplasm intrabodies cannot form their stabilizing disulfide linkage(s), only those that are of sufficient stability can tolerate the absence of the disulfide linkage and be expressed in functional form (11) . Traditionally, single chain Fvs (scFv, a molecule consisting of an Ab heavy chain variable domain, V H , and a light chain variable domain, V L , joined together by a linker) have been used as intrabodies. More recently, the feasibility of three types of sdAbs, V L s, V H s, and V H Hs (V H s derived from camelid heavy chain antibodies), as intrabodies has also been demonstrated (10 -15) . Although they offer a comparable affinity (11, 14, 16) , sdAbs have higher stability, solubility, and expression level than scFvs (16 -18) and thus are more efficacious as intrabodies (10, 11, 15) . Intrabodies can be derived from monoclonal antibodies or Ab display libraries, e.g., Ab phage display libraries (6) .
To combat neurodegenerative diseases resulting from death of postmitotic neuronal cells, it is important to understand how this process occurs. One proposed mechanism of apoptosis is the intrinsic reactive oxygen mediated pathway (19) . Excess reactive oxygen species (ROS) released from the mitochondria has the ability to activate Bax leading to permealization of the outer mitochondrial membrane. As a result, various apoptoticinducing factors and specific proapoptotic factors such as cytochrome c are released into the cytosol leading to a destructive apoptotic cycle and further ROS generation (20) . We hypothesized that since Bax is a key component in this pathway, single-domain intrabodies inhibiting Bax function should also be effective inhibitors of apoptosis. We, thus, panned a llama V H H phage display library against Bax and identified several Baxspecific V H Hs. Functional characterization of these V H Hs showed that as intrabodies the V H Hs were nontoxic in their mammalian host cells and effectively inhibited apoptosis induced by oxidative stress. These results also confirm the key role of Bax protein in apoptosis under oxidative stress.
MATERIALS AND METHODS

Panning and phage enzyme-linked immunosorbent assays
A llama V H H phage display library described previously was used in panning experiments (17) . Panning against recombinant Bax protein was performed as described previously (17) except that in the second and the third rounds, the phage elution additionally involved MgCl 2 /HCl treatment. First, the bound phages in the microtiter wells were eluted with 200 l and neutralized with 100 l 1 M Tris-HCl, pH 7.4 (17) . Then, the emptied wells were subsequently incubated with 100 l of 4 M MgCl 2 at room temperature for 15 min. The eluted phage was removed and the wells were incubated with 100 l of 100 mM HCl for 5 min at room temperature. The MgCl 2 /HCl-eluted phages were pooled, neutralized with 1.5 ml of 1 M Tris-HCl pH 7.4, and combined with the triethylamine-eluted phages. One milliliter of the combined phages was used to infect E. coli for overnight phage amplification, and the remaining 1 ml was stored at Ϫ80°C for future reference. V H H clones were identified from the titer plates by plaque-polymerase chain reaction and sequencing as described previously (21) . After being panned, phage clones from titer plates were amplified in microtiter wells (21) and screened for binding to Bax protein by standard enzymelinked immunosorbent assays (ELISA) using a horse radish peroxidase/anti-M13 monoclonal antibody (mAb) conjugate (GE Healthcare, Baie d'Urfe, QC, Canada) as the detection reagent.
E. coli protein expression and purification
V H Hs were cloned from the phage vector into the expression vectors by standard cloning techniques. E. coli expression of V H Hs and subsequent purification by immobilized metal affinity chromatography were performed as described previously (21) . Protein concentrations were determined by A 280 measurements using molar absorption coefficients calculated for each protein (17) .
Cell culture
Human neuroblastoma (SHSY-5Y) cells (American Type Culture Collection, Manassas, VA) were grown in complete medium consisting of Dulbecco's modified Eagle's medium (DMEM) Ham's F-12 media (Invitrogen Canada, Burlington, ON, Canada) with the addition of 2 mM l-glutamine (Invitrogen Canada) and 10% (v/v) FBS (Sigma, Oakville, ON, Canada) and 20 g/ml gentamicin (Invitrogen Canada); 200 g/ml Geneticin (G418; Invitrogen Canada) was added to all transfected cells. The cells were incubated at 37°C with 5% CO 2 and 95% humidity.
Statistical analysis
P values for all graphs were calculated using Statistica Application for Windows 95, where P values Ͻ0.05 were assumed to be statistically different.
Mitochondria isolation and ROS measurement
SHSY-5Y cells were grown to 70% confluence in 10 ml Petri dishes. The intact mitochondria were isolated from these cells using a previously published method (22) . Mitochondria were suspended in solution containing 0.25 M sucrose, 1 mM MgCl 2 , 10 mM HEPES, 4 mg/ml PHPA (p-hydroxyphenyl acetate), and 20 mM succinate (Sigma Canada). Mitochondrial ROS generation is measured by H 2 O 2 generation rate, determined fluorimetrically by measurement of the oxidation of PHPA coupled to the reduction of H 2 O 2 by horseradish peroxidase (Sigma Canada), based on a previously published protocol (22) .
Detection of cytochrome c release by Western blot
Cytochrome c release was detected after incubating isolated mitochondria with V H H for 15 min followed by exposure to Bax for 5 min, in solution containing 0.25 M sucrose, 1 mM MgCl 2 , 10 mM HEPES, and 20 mM succinate. Samples were then spun down at 10,000 g for 5 min separating proteins of whole intact mitochondrial (pellet) and those released due to mitochondrial membrane permealization (supernatant). Pellet and supernatant fractions were solubilized in SDS-PAGE loading buffer, and proteins (50 mg protein/well) were then subjected to a 12% SDS-PAGE, followed by transfer on nitrocellulose membrane. The blots were probed with monoclonal anticytochrome c antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) followed by washing and a second incubation with horse radish peroxidase-conjugated antimouse antibodies. The blots were developed using a ChemiGlow West kit (Alpha Innotech, San Leonardo, CA) and recorded using an Alpha Innotech Imaging System. Integrated density values were calculated using Chemilmanager V5.5 program for Windows 95. HindIII/NotI site of pEGFP-N1 (V H H) (BD Biosciences, Mississauga, ON, Canada). The V H H recombinant vectors were propagated in E. coli and were purified using QIAprep Spin Miniprep kit according to the manufacturer's instructions (QIAGEN, Mississauga, ON, Canada). The purified plasmids were subsequently used to transfect SHSY-5Y cells using Fugene 6 Transfection Reagent (Hoffmann-La Roche Ltd., Mississauga, ON, Canada) following the manufacturer's protocol. Forty-eight hours after transfection, cells were transferred to complete DMEM media (as described above) containing 300 g/ml geneticin for selection of positive transfected cells for 1-2 wk. Stable cell lines were subsequently maintained in complete DMEM media as described above with 200 g/ml geneticin.
Mammalian cell transfection
Detection of V H H expression in mammalian cells by Western blot
Equal amounts of protein extract (50 g) from control cells containing GFP only and cells expressing specific GFP linked anti-Bax V H Hs were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The blots were probed with monoclonal anti-GFP antibodies (Sigma, St. Louis, MO) after which they were washed and incubated with horseradish peroxidase-conjugated anti-mouse antibodies. The blots were developed as described above.
Induction of oxidative stress
Working solutions of H 2 O 2 were made by diluting a 10 M stock of H 2 O 2 solution with distilled water to a concentration of 100 mM. SHSY-5Y cells were grown to ϳ70% confluence. Oxidative stress was induced by incubating the cells in complete media containing either 100 M or 200 M H 2 O 2 for 1 h or 3 h at 37°C. The media were then replaced with fresh, complete media (without H 2 O 2 ), and the cells were incubated for different time periods to monitor apoptotic features and oxidative stress parameters.
Monitoring nuclear morphology
Nuclear morphology was monitored as an indicator for apoptosis in cells by staining cells with Hoechst 33342 (Invitrogen Canada) to a final concentration of 10 M. After incubating for 10 min at 37°C, the cells were then examined under a fluorescence microscope (Zeiss Axioskope 2 Mot plus, Gottingen, Germany) and fluorescence pictures were taken using a camera (QImaging, Gottingen, Germany). The images were processed using Improvision OpenLab v3.1.2, Jasc Paint Shop Pro v8.00, and Adobe Photoshop v8.0.
Mitochondrial membrane potential detection and measurement
Mitochondrial membrane potential was detected using JC-1 mitochondrial specific dye (Invitrogen Canada). The cells were treated with 10 M JC-1 and incubated for 40 min at 37°C. The cells were observed under the fluorescent microscope, and fluorescence pictures were taken and processed as described above. Alternatively, mitochondrial membrane potential stability was also quantified using Dual Sensor: MitoCasp Assay (Cell Technology, Mountain View, CA, USA) as per manufacturer's instructions.
Monitoring plasma membrane flipping
Annexin V (Invitrogen Canada) was used to monitor plasma membrane flipping in cells according to the manufacturer's instructions. After being incubated for 15 min at 37°C, the cells were examined under the fluorescence microscope and fluorescence pictures were taken and processed as described above.
Lipid peroxidation determination
Lipid peroxidation in cells was determined using the thiobarbituric acid-reactive substances (TBARS) reaction with malondialdehyde and related compounds as described previously (23) .
Caspase 3/7 activation measurement
The activation of caspase 3/7 was measured in cells using Apo 3/7 HTS High Throughput Screen Assay kit (Cell Technology) as per manufacturer's instructions.
RESULTS
Identification of anti-Bax V H Hs
We initiated the search for antiapoptotic single-domain intrabodies by panning a naive llama V H H phage display library (17) against Bax. Screening of 38 colonies from the second and the third rounds of panning gave six different V H H sequences, namely, Bax1, Bax2, Bax3, Bax4, Bax5-1, and Bax5-2, occurring at frequencies of 9, 24, 2, 1, 1, and 1, respectively (Fig. 1A) . All six V H Hs bound strongly to Bax but not to a control BSA in phage ELISAs (Fig. 1B) . V H Hs were expressed in fusion with C-terminal c-Myc-His 5 tag in E. coli and purified to homogeneity for subsequent functional studies.
Functional characterization of V H Hs in vitro: inhibition of Bax activity in isolated mitochondria
The ability of the six V H Hs to inhibit Bax was tested by monitoring Bax-induced ROS generation from isolated mitochondria, which as mentioned above correlates with mitochondrial destabilization (20) . We hypothesized that if the anti-Bax V H Hs are inhibitory toward Bax, preincubation of isolated mitochondria with antiBax V H Hs, followed by the addition of Bax should prevent Bax from permealizing the mitochondria and lead to a reduced ROS release from mitochondria into the solution. Indeed, for all the V H Hs (Bax2, Bax 3, Bax 4, Bax 5-1, and Bax 5-2) tested, we observed a significant decrease in ROS release from mitochondria incubated with V H Hs and Bax compared to the fractions of mitochondria incubated with Bax alone or with Bax and an irrelevant V H H (PϽ0.05; Fig. 2A ). Specifically, Bax3 and Bax5-2 V H Hs showed greatest potential as Bax inhibitors decreasing ROS production from mitochondria by ϳ55 and 90%, respectively.
Permeability of the mitochondria was also monitored through detection of cytochrome c release by Western blot. Cytochrome c is released from the inner mitochondrial space into the solution when this organelle is destabilized (19) . Thus, stable and healthy mitochon-dria are expected to show strong retention of cytochrome c. As in the previous ROS assay, isolated mitochondria in solution were preincubated with V H Hs followed by the addition of Bax (mitochondria alone and in presence of recombinant Bax protein only were used as controls). When incubated with Bax, significantly higher cytochrome c release was seen in the supernatant fraction of the mitochondria incubated with recombinant Bax protein alone compared to those incubated with V H Hs and Bax (Fig. 2B) ; these findings were further confirmed by calculating the percent integrated density value of each band intensity (Fig.  2C ). Equal protein sample loading was confirmed in both instances by Ponseau S staining of the blots before incubation with blocking solution (data not shown). Conversely, mitochondria preincubated with V H Hs showed significantly more cytochrome c in their pellet fraction (representing intact mitochondrial membrane) than the ones with no preincubation, demonstrating that the V H Hs decreased the permeability of mitochondria initiated by Bax (data not shown).
Functional characterization of anti-Bax V H Hs in situ inhibition of apoptosis by V H Hs when expressed as intrabodies in mammalian cells
The assays performed on isolated mitochondria clearly indicated that the V H Hs can bind and prevent Bax activity in solution and in isolated mitochondria. We further studied the effects of the V H Hs as intrabodies inside intact cells. SHSY-5Y cells were transfected with all six V H H genes in fusion with RFP and GFP ( Fig. 3A) and 12 stable cell lines, each expressing a unique V H H fusion protein, were obtained. In addition, stable control cell lines containing genes for an irrelevant V H H (PTH50, a parathyroid-hormone binding V H H) or fluorescent proteins alone were established. Expression of the V H Hs from both transient and stable transfections was confirmed by Western blot analysis of cell lysates using anti-GFP Ab (Fig. 3B) . In lane 1, cells containing GFP produce a band just under 30 kDa, consistent with the GFP molecular mass 27 kDa (24), although cells expressing each of the six anti-Bax V H H-GFP fusion proteins produce a band at ϳ40 kDa, very close to the theoretical value, 41 kDa (Bax5-2, Bax3, and Bax2 are shown). Fluorescence microscopy was also used to "visualize" expression of V H H-RFP or V H H-GFP fusion proteins in cells (Fig. 3C , Bax4-RFP is shown).
To assess the protective capabilities of the six Baxspecific V H Hs in context of intrabodies, we again monitored the resistance of cells to apoptosis under oxidative stress. As previously discussed, oxidative stress due to mitochondrial ROS elevation has been linked to the activation of Bax and ultimate destabilization of the mitochondria leading to apoptosis (19, 25) . Thus, we hypothesized that if the V H H intrabodies block Bax activity during oxidative stress, apoptosis would be prevented. In previous studies, it was shown that exposure of SHSY-5Y cells to 100 M H 2 O 2 for 1 h results in a significant increase in the rate of apoptosis (26) . By implementing this condition to the stable cell lines containing either a V H H gene or a control gene, we monitored the cells 24 h after H 2 O 2 treatment for apoptotic features. To this end, the cells were stained with Hoechst reagent where brightly stained and condensing nuclei would be indicative of apoptotic cells (Fig. 4) .
Untreated SHSY-5Y cells not expressing any V H H were used as a positive control with ϳ96% cell viability (Fig. 5) . When the three negative control cell lines (nontransfected, transfected with GFP, or RFP only or transfected with PTH50) were exposed to 100 M H 2 O 2 , a significant number of cells underwent apoptosis 24 h after the treatment as indicated by brightly stained condensed nuclei. Thus, the number of nonapoptotic healthy cells was reduced to ϳ50% (Fig. 5) . Interestingly, the cells containing any of the six anti-Bax V H H intrabodies in fusion with GFP or RFP showed very good resistance to the similar treatment with 87-93% viabilities and varied significantly from all the control treated cell lines (PϽ0.05). These values are very close to the viability values for the untreated, nontransfected SHSY-5Y cells (96%), demonstrating the effectiveness of the V H H intrabodies in preventing apoptosis.
Annexin V in parallel with Hoechst staining (Fig. 6 ) was used to monitor plasma membrane flipping (another indicator of the early phase of apoptosis) and Complementarity determining region 1 (CDR1), CDR2, and CDR3 sequences appear sequentially in bold text. Dots represent sequence identity with Bax2 V H H, and dashes are included for sequence alignment. Kabat numbering system is used (32) . B) Binding analyses of anti-Bax V H Hs. G raph shows binding, by ELISA, of V H H-displayed phages to immobilized Bax. None of the V H H-phages bound to BSA, and the phage alone showed a background binding to Bax. Definitive conclusion with respect to relative affinity of the V H Hs for Bax cannot be drawn, because amount of V H H phage added during binding step is not known.
nuclear condensation, respectively. These assays further confirmed the above finding that apoptosis was inhibited in the cells expressing anti-Bax V H Hs. Moreover, the expression of V H Hs was nontoxic to their host cells as growth and proliferation was not hindered. The V H H-containing cells that survived the oxidative stress were viable and fully functional after several days after H 2 O 2 treatment (Fig. 7) , as their growth rates were similar to those without any oxidative stress.
Intrabodies prevent mitochondrial membrane potential collapse after oxidative stress and render the host cells resistance to apoptosis at higher level of oxidative stress
To further assess the degree of potency of the V H H intrabodies in preventing apoptosis, we increased the stress conditions. When the H 2 O 2 (100 M) exposure time was increased to 3 h, cells expressing V H Hs showed almost identical survival rates as when exposed for 1 h (data not shown). When treated with 200 M H 2 O 2 for 1 h, control cell lines (containing no or the irrelevant V H H) showed a very high degree of apoptosis and poor survival as measured by Hoechst staining and trypan blue exclusion assay. Conversely, almost all cell lines contain each of the V H Hs showed significant survival, with the most promising being the cells containing Bax1, Bax2, Bax3, and Bax5-2 V H Hs (Fig. 8) . As before, the cell viabilities of the anti-Bax V H H expressing cells were shown to be statistically higher than all the control treated cell lines (PϽ0.05). Importantly, these results are in agreement to the ROS data ( Fig.  2A) obtained using V H Hs in presence of isolated mitochondria. In addition, JC-1 staining of mitochondrial membrane potential after the 200 M H 2 O 2 /1 h treatment (Fig. 9) showed stable mitochondrial potential in cells expressing the anti-Bax V H Hs comparable to the nontransfected, nontreated control SHSY-5Y. These results were further quantified using a newly developed mitochondrial membrane potential assay called MitoCasp assay. In this assay, a cell permeable cationic dye when exposed to cell fractions is accumulated in healthy mitochondria and exhibits a strong fluores- cence signal (in the red), which can be measured using a fluorescence plate reader. Collapse of mitochondrial membrane potential leads to a decrease in the fluorescence. Results shown in Fig. 10 indicated that there was a considerable decrease in the fluorescence in the nontransfected SHSY-5Y cells after 100 M H 2 O 2 /1 h treatment, compared to the nontreated control cells and the treated Bax5-2 expressing cells (PϽ0.05). Conversely, cells expressing Bax5-2 V H H produced strong fluorescence comparable to control nontransfected/nontreated SHSY-5Y cell (PϾ0.05). These data further confirm the ability of these intrabodies to protect the mitochondria from Bax-mediated permealization in the presence of oxidative stress (Fig. 10) .
In addition, we also monitored lipid peroxidation, another indicator of oxidative stress. When cells are exposed to higher ROS levels, most commonly due to mitochondrial damage, lipid deterioration is observed (23) . Lipid peroxidation was assessed for cells expressing anti-Bax V H Hs as well as nontransfected cells (with and without treatment), 24 h after exposure to 100 M H 2 O 2 for 1 h. We observed a significant decrease in lipid peroxidation in cells expressing anti-Bax V H Hs, compared to nontransfected/treated SHSY-5Y cells ( Fig. 11 ; Bax3 and Bax5-2 are shown; PϽ0.05). This indicates that the V H Hs are able to block mitochondrial permeabilization by Bax, thus, limiting the leakage of various apoptotic inducing factors and ultimately preventing cell death.
Activation of executioner caspases 3/7 was also monitored in V H H-transfected cells using a high throughput screen for caspases 3/7 assay kit measuring the activity of these proteases as an increase in fluorescence. Specifically, this kit utilized a quenched (z-DEVD) 2 -R110 peptide, which is cleaved by active caspases 3/7, to release R110 free dye from the quenching caspase substrate DEVD. In this way the increase in fluorescence is indicative of capsase 3/7 activation in vivo. For this assay, oxidative stress was induced in control nontransfected (nontreated or treated) cells and Bax5-2 V H H-expressing cells (100 M H 2 O 2 /1 h) and caspase activation was measured after 6 h. We observed a significant increase in fluorescence indicative of strong caspase activation in control nontransfected/treated SHSY-5Y cells, which was significantly lower in nontransfected/ nontreated and Bax5-2-expressing cells (PϽ0.05; Fig. 12 ).
Presence of GFP or RFP as fusion proteins does not alter the antiapoptotic activities of anti-Bax intrabodies
To further show that antiapoptotic activities of the anti-Bax V H Hs are independent of their fusion context, cell lines of V H H intrabodies without fusion to GFP or RFP were also established. These cells were also monitored for their ability to resist oxidative stress induced apoptosis by treatment with 200 M H 2 O 2 for 1 h. Apoptosis was monitored after 24 h using Hoechst staining to detect apoptotic nuclei. As shown in Fig. 13 , cells expressing the "unfused" anti-Bax V H Hs have cell viability rates that were significantly higher than all the treated control cell lines (PϽ0.05), indicating that the cells transfected without the fluorescent marker protein have comparable cell survival rates to their respective cells with fused V H H. These results clearly indicate that inhibition of apoptosis was solely due the V H Hs and not due to the marker fusion protein. 
DISCUSSION
Here we report for the first time the identification of several nontoxic, Bax-inhibiting V H H intrabodies that phenotypically transform their host cells into cells that are resistant to oxidative-stress-induced apoptosis. This opens new opportunities for treating neurodegenerative diseases that involve cell death induced by oxidative stress and Bax activation. Recent observations by Kuwana et al. (27) indicated that Bax initiates mitochondrial permeabilization by associating with Bid and lipids. Therefore, V H Hs could inhibit the Bax function by binding to Bax at several sites: on the Bid-binding site, on the transmembrane domain, or at the site involved in Bax-Bax dimerization and activation. Since for all V H Hs the same concentration of V H H was used, the differences in the degree of inhibition by different V H Hs suggest that the V H Hs should be blocking different sites on Bax. Specifically, Bax5-2 must be binding at the site critically involved in Bax function as it had the maximum inhibitory effect (in both in vitro and in vivo studies). Alternatively, the differences in the degree of inhibition by different V H Hs may be due to their differences in their affinity for Bax.
The efficacy of intrabodies is determined by their affinity, stability, and expression levels inside cells. V H Hs are preferable over scFvs for intrabody applications because of higher stability and expression levels. Binders obtained previously from the naive V H H phage display library (17) used in this study have had K D s in the low micromolar range with K D s of a few micromolars at best (28, 29) . In accordance with this, one of the anti-Bax V H Hs analyzed by surface plasmon resonance had a K D of 40 M (data not shown). In the light of their low affinity, the V H Hs in this study must have owed their potency to their high stability and expression levels. This underlines once again the importance of Ab stability, expression levels, and the suitability of V H Hs as intrabodies. Moreover, the inherent stability of V H Hs eliminates the need for further screening of lead intrabodies for stability (9, 30) . The smaller size of the V H Hs is an advantage in cases where the intrabody needs to travel through intracellular membrane pores to exert its effect (15) . If required, the intrabody potency of the current V H Hs can be further enhanced by increasing their affinity by in vitro affinity maturation experiments.
There are several well-known and accepted apoptotic pathways, including extrinsic pathways involving cell surface receptors, as well as intrinsic pathways stemming from caspase-dependent and -independent mechanisms. One important intrinsic apoptotic pathway is ROS-induced apoptosis which results in destabilization of the mitochondria and release of proapoptotic proteins resulting in cell death. Due to the extreme vulnerability of the brain to oxidative stress, targeting this particular ROS-mediated pathway is of primary importance for the treatment of neurodegenerative diseases. The sensitivity of neuronal cells can be attributed to the large O 2 exposure as well as limited antioxidants in the brain. In addition, a significant fraction of all brain lipids is polyunsaturated and, thus, easily oxidizable, and finally, the presence of iron in various regions of the brain has also been implicated in oxidative damage because of its catalytic role in production of radicals (31) . Observations that the V H Hs showed specific binding to Bax protein and were capable of inhibiting Bax-induced mitochondrial dysfunction in in vitro assays suggest that inhibition of apoptosis by these intrabodies must be due to their Bax-modulating activity in the cells.
To rule out the possibility that intrabodies might be acting simply as general antioxidants, we repeated our experiments using cells expressing an irrelevant V H H intrabody PTH50. The results clearly indicated that there was no protection against apoptosis by PTH50. Therefore, we can conclude that the specific binding to Bax and subsequent modulation of this proapoptotic protein by the anti-Bax V H Hs is responsible for protection against oxidative-stress-induced apoptosis. Furthermore, we have shown that the presence of the anti-Bax intrabodies neither inhibit cell growth nor affect cellular morphology, suggesting that the V H Hs are well tolerated in the cells and might not interfere with any other processes.
The interaction of Bax with VDAC on the mitochondrial outer membrane has been reported as a possible mechanism for Bax-induced permealization of the mitochondria and induction of apoptosis (33) . Our in vitro and in vivo results have both shown that the presence of the anti-Bax V H Hs can protect the mitochondria from Bax associated damage (by decreasing ROS generation and preventing MMP collapse, respectively). Our preliminary immunoprecipitation studies using anti-VDAC antibodies to coprecipitate Bax with VDAC from cell lysates of nontransfected and Bax5-2 expressing cells have shown that there is a disruption of Bax-VDAC association in the Bax5-2-expressing cells. This suggests that at least in the case of Bax5-2, the anti-Bax V H H may work by preventing the interaction between Bax and VDAC, thus inhibiting the opening of the PTP and overall apoptosis induced by oxidative stress.
Currently, several research groups are working toward utilizing intrabodies as therapeutic agents in various diseases (6) . Beside their direct use as intrabodies in the context of gene therapy, the present V H Hs could also be used as means to fish out specific and nontoxic small molecular mass inhibitors of Bax from pharmacophore libraries. Furthermore, the anti-Bax V H Hs and the oxidative-stress-resistant stable cell lines in this study would be valuable research tools to elucidate the mechanism of mitochondrial permeabilization and apoptosis in general. Finally, the work presented here can be extended to other apoptotic proteins for obtaining a versatile pool of V H Hs as a source of therapeutics and probes for delineating the mechanism of apoptosis.
We thank Natasha Sharda and Ariel Burns for technical assistance. We thank Dr. M. Bani for technical assistance and scientific input and Dr. Roger MacKenzie and Tomoko Hirama for performing SPR experiments. We thank Tom Devecseri for helping with photography and imaging. This Figure 12 . Caspase 3/7 activation was prevented by anti-Bax intrabodies. A high throughput screening assay was used to quantify activation of Caspase 3/7 in nontransfected (ntf) control (nontreated, ntr, or treated, tr) cells as well as those expressing Bax5-2 V H Hs. A fluorescence plate reader was used to detect fluorescence produced due to high levels of active caspases. Oxidative stress was induced using 100 M H 2 O 2 for 1 h and readings were taken after 6 h. Cells expressing Bax5-2 V H H produced low levels of fluorescence comparable to control cell line without any treatment [ntf (ntr)], indicating a decrease in caspase activation due to protection of mitochodria by the anti-Bax intrabody. In contrast, nontransfected, treated cells [ntf (tr)] produced significantly high levels of fluorescence, with P values less than 0.05 when compared to both ntf (ntr) and Bax5-2 expressing cells, indicating strong caspase activation in these control cell lines. To assess the protective capabilities of the six specific V H Hs as intrabodies, we once again monitored the oxidative stress resistance. As previously discussed, oxidative stress due to mitochondrial ROS elevation has been linked to the activation of Bax and ultimate destabilization of the mitochondria leading to apoptosis. Thus, we hypothesized that if the V H H intrabodies block Bax activity during oxidative stress, apoptosis should be prevented. In previous studies, it has been shown that exposure of SHSY-5Y cells to 100 M H 2 O 2 for 1 h results in a significant increase in the rate of apoptosis. By implementing this condition to the stable cell lines containing either V H Hs or control genes, we monitored these cells 24 h after treatment for apoptotic features. Specifically, cells were stained with Hoechst reagent to monitor nuclear morphology; brightly stained and condensing nuclei were indicative of apoptotic cells.
Cell viability counts for stable cell lines expressing anti-Bax intrabodies and treated with 100 M H 2 O 2 were virtually the same as those of nontreated/nontransfected cells and significantly higher than those for the control-treated cells: nontransfected GFP-transfected, RFP-transfected, and PTH50-RFP-transfected (Fig. 2) . Similar results were obtained for experiments with 200 M H 2 O 2 /1 h treatment conditions.
In addition, the ability of the anti-Bax V H Hs to prevent mitochondrial destabilization and apoptosis was further confirmed using fluorescence staining JC-1 and Hoechst to monitor mitochondrial membrane potential and nuclear condensation, respectively. These findings were also supported by annexin V staining, lipid peroxidation, intrinsic ROS production, and caspase activation (data shown in the full-length manuscript). 
CONCLUSIONS AND SIGNIFICANCE
In this study, we have reported for the first time the identification of several nontoxic, Bax inhibiting V H H intrabodies that phenotypically transform their host cells into cells that are resistant to oxidative-stressinduced apoptosis through blocking the proapoptotic effect of Bax on the mitochondria (Fig. 3) . This opens new opportunities for treating neurodegenerative diseases that involve cell death induced by oxidative stress and Bax activation.
Currently, several research groups are working toward using intrabodies as therapeutic agents in various diseases. Beside their direct use as intrabodies in the context of gene therapy, the present V H Hs could also be used as means to fish out specific and nontoxic small molecular mass inhibitors of Bax from pharmacophore libraries. Furthermore, the anti-Bax V H Hs and the oxidative-stress-resistant stable cell lines in this study would be valuable research tools to elucidate the mechanism of mitochondrial permeabilization and apoptosis in general. Finally, the work presented here can be extended to other apoptotic proteins for obtaining a versatile pool of V H Hs as a source of therapeutics and probes for delineating the mechanism of apoptosis. 
